Skip to main content

Security report for allergan.com

AbbVie Inc. · Healthcare · United States

Medium risk. 4 critical or high findings in Security headers and SSL/TLS.

Security score

72/100

Risk levelMedium

0–100, higher is better. How it is calculated

AbbVie Inc. is a global pharmaceutical company focused on discovering and developing innovative medicines across multiple therapeutic areas including oncology, immunology, aesthetics, and eye care. The website reflects the integration of Allergan into AbbVie, showcasing a broad portfolio of products and services targeted at patients, healthcare professionals, and job seekers. The company maintains a strong market position as an enterprise-level healthcare provider with a comprehensive digital presence. Technically, the website is built on Adobe Experience Manager, leveraging modern web technologies and third-party analytics tools such as Google Tag Manager, Siteimprove, and OneTrust for cookie consent. The site demonstrates good performance, mobile optimization, and accessibility features, with a strict Content Security Policy enhancing security posture. Security-wise, the site uses HTTPS with strong SSL configuration and implements security best practices including CSP and cookie consent mechanisms. However, additional security headers could be added to further harden the site. No vulnerabilities or exposed sensitive data were detected. Privacy compliance is well addressed with clear privacy and cookie policies and GDPR compliance indicators. Overall, the website is professional, trustworthy, and well-maintained, though the absence of WHOIS data for the domain is unusual and warrants further investigation. The site is not blocked by any WAF or security challenge, allowing full content access and analysis.

Scanned

NIS2 and GDPR posture

GDPR outside view
88/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

4 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1
    • High

      Weak SSL Key Length

      SSL certificate uses 256-bit key, which is considered weak

      What to do: Use at least 2048-bit RSA or 256-bit ECC key

      • CWE-326
      • OWASP A04:2025
      • Mozilla TLS: Mozilla Server Side TLS 6.0 intermediate: rsa_key_size 2048

Need hands-on remediation? Email guard@offseq.com

Keep watching allergan.com

This scan found 19 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
37
Security headers
35
Email security
85
DNS health
85
Network security
100
GDPR outside view
88
Average
72

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Breach exposure

Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.

Brand lookalikes

Add-on

Domains that imitate allergan.com and could be used for phishing or spoofed email, tracked in OffSeq Breach.

Tracked
20
Registered
20
Resolving
20
High or critical
0

Last checked 2026-06-27

Masked preview

  • al••••••.comMediumhomoglyph
  • al•••••.comMediumomission
  • al••••••.comMediumtransposition

See the full lookalike list

A one-off add-on that lists up to 20 of the highest-risk lookalikes of allergan.com with registration, mail-server, certificate and DNS signals.

Select it in the checkout above.

Lookalike data refreshes continuously. Monitoring on Breach alerts you when a variant is registered, gains a mail server or starts serving HTTPS.

Open in Breach(opens in a new tab)Monitor on Breach(opens in a new tab)

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

AbbVie operates in the healthcare sector with a focus on pharmaceutical research, development, and commercialization. The company benefits from the acquisition of Allergan, expanding its portfolio into aesthetics and eye care. Revenue streams include branded pharmaceuticals, patient support services, and contract manufacturing. The target customers include patients, healthcare providers, and investors. The company has a global footprint with a large workforce (~50,000 employees). Strategic partnerships and subsidiary domains support its operations. The website content and structure indicate a mature, enterprise-grade business with strong branding and market presence.

Security posture

The website exhibits a mature security posture with HTTPS enforced and a comprehensive Content Security Policy. Use of cookie consent tools and third-party analytics is managed with user consent. No direct security policies or incident response contacts are published on the analyzed page, which could be improved. No known vulnerabilities or security issues were detected in the content or scripts. The absence of WHOIS data is a minor concern but does not currently impact the trustworthiness of the site given the strong corporate branding and external validation via social media and partner links.

Recommendations

  1. Add additional security headers such as HSTS, X-Frame-Options, and X-Content-Type-Options to enhance protection against common web attacks.
  2. Publish a dedicated security policy and incident response contact information to improve transparency and readiness.
  3. Regularly audit and update third-party scripts and analytics tools to mitigate supply chain risks.
  4. Investigate the WHOIS data unavailability to ensure domain registration transparency and legitimacy.
  5. Enhance data retention policy disclosures related to analytics and user data for improved privacy compliance.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
AbbVie Inc.
Description
AbbVie discovers and develops innovative medicines for various therapeutic areas including oncology, immunology, aesthetics, and eye care. The site highlights the integration of Allergan into AbbVie and offers information about products, careers, and corporate information.
Key services
Pharmaceutical products, Medical aesthetics, Patient support, Contract manufacturing
Content quality
excellent
Branding
consistent

Technology

Stack
Adobe Experience Manager (AEM), Google Tag Manager, YouTube iframe API, OneTrust Cookie Consent, Brightcove, Siteimprove Analytics, Cloudflare Insights
Frameworks
Content Security Policy
Platforms
Web
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
85/100
Good practices seen
  • Strict Content Security Policy
  • Use of HTTPS
  • Cookie consent mechanism

Analytics and tracking

Services
Google Analytics, Siteimprove Analytics, Clarity, Reddit Analytics, TikTok Analytics, LinkedIn Analytics
Tracking level
extensive
Privacy practices
good

Advertising

Ad networks
Google DoubleClick, The Trade Desk, Ads Twitter
Tracking pixels
Siteimprove Analytics, Clarity, Reddit Pixel, TikTok Analytics, LinkedIn Ads
Marketing tools
OneTrust Cookie Consent
Transparency
good

Site quality

Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content and no blocking detected.
  2. Strong use of third-party analytics and marketing tools with consent mechanisms.
  3. Comprehensive corporate information and product details present.
  4. No direct company contact emails or phone numbers found on this page; contact forms and social media links are primary contact methods.
  5. WHOIS data unavailable, which is unusual for a large enterprise domain.
Technical notes

Notes

The website is built on Adobe Experience Manager, a robust enterprise CMS platform, indicating a high level of technical maturity. It integrates multiple third-party services for analytics, marketing, and video content delivery. The site uses modern web standards including strict Content Security Policy and asynchronous script loading for performance. Mobile optimization and accessibility are well implemented. Performance is moderate, likely due to the extensive use of external resources and tracking scripts. There is an opportunity to optimize loading times and reduce third-party dependencies to improve user experience further.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with allergan.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review allergan.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.